The impact of the global bacille Calmette-Guérin shortage on treatment patterns: population-based data

BJU Int. 2018 Feb;121(2):169-172. doi: 10.1111/bju.14065. Epub 2017 Nov 15.

Authors

Affiliations

¹ Department of Surgery, Austin Health, University of Melbourne, Heidelberg, Vic., Australia.
² Faculty of Medicine, University of Queensland, Brisbane, Qld, Australia.
³ Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic., Australia.
⁴ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.

PMID: 29072817
DOI: 10.1111/bju.14065

No abstract available

Publication types

Letter

MeSH terms

Adjuvants, Immunologic / supply & distribution
Adjuvants, Immunologic / therapeutic use*
Australia
BCG Vaccine / supply & distribution
BCG Vaccine / therapeutic use*
Carcinoma in Situ / drug therapy*
Carcinoma, Transitional Cell / drug therapy*
Drug Prescriptions / statistics & numerical data*
Humans
Neoplasm Recurrence, Local / drug therapy*
Standard of Care
Urinary Bladder Neoplasms / drug therapy*

Substances

Adjuvants, Immunologic
BCG Vaccine